Key Takeaways Super Micro Computer is experiencing substantial growth, with fiscal 2024 revenue nearing $14.9 billion (a 110% increase) and fiscal 2025 forecasts projecting between $21.8 billion and $22.6 billion....
Key Takeaways Toast demonstrated robust revenue growth of 24.37% in Q1 2025, outperforming many peers in the financial technology sector. The company raised its full-year 2025 adjusted EBITDA guidance to...
Key Takeaways Blue Owl Capital distinguishes itself through a disciplined, asset-light model focused on recurring fee income from permanent capital, offering stability over high-yield, leveraged strategies. The firm reported strong...
Key Takeaways Elevance Health’s stock has experienced a significant drawdown in 2025, falling approximately 50% from its all-time high amid sector-wide turbulence. The decline is attributed to a combination of...
Key Takeaways Walmart has reportedly increased prices on certain goods by as much as 51% in 2025 in direct response to tariffs imposed under President Trump’s trade agenda, testing its...
Key Takeaways Improving Financial Health: Lemonade is demonstrating progress with strong growth in in-force premium (IFP), which reached $873 million in Q4 2024, and a declining gross loss ratio, which...
The relationship between the U.S. Treasury and the Federal Reserve has rarely been as scrutinised as it is in 2025, with Treasury Secretary Scott Bessent emerging as a pivotal figure...
Key Takeaways Valuation Discrepancy: As of mid-2025, Eli Lilly’s market capitalisation of approximately $850 billion is more than double that of Novo Nordisk’s $330 billion, despite both companies dominating the...
The stock of Zeta Global Holdings Corp (NYSE: ZETA) has shown notable momentum in recent weeks, with indications of a potential breakout as it tests key technical levels in premarket...
Harrow, Inc. presents a compelling opportunity in ophthalmic pharmaceuticals, boasting a vertically integrated business model that captures value across the entire product lifecycle. With a focus on branded and compounded...
